How specific are therapeutic monoclonal antibodies?
Self
Colin H
CH
Diagnostic and Therapeutic Technologies, School of Clinical and Laboratory Sciences, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, UK. Electronic address: C.H.Self@ncl.ac.uk.
Thompson
Stephen
S
Diagnostic and Therapeutic Technologies, School of Clinical and Laboratory Sciences, Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, UK.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D061067:Antibodies, Monoclonal, Humanized; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C509303:TGN-1412